- Barrons.com•12 hours ago
Earlier today, we noted that JPMorgan had warned clients to avoid Valeant Pharmaceuticals International (VRX) ahead of its earnings. In an appearance on CNBC, however, Legg Mason fund manager Bill Miller argued that Valeant's shares could double in three years. From Bloomberg: Bill Miller, who is best known for beating the S&P 500 Index for 15 straight years, says he has been buying Valeant Pharmaceuticals International Inc. and financial stocks such as OneMain Holdings Inc (OMF).
- TheStreet.com•14 hours ago
Legendary value investor Bill Miller called Valeant Pharmaceuticals (VRX) the 'most toxic' stock in the market, but explained why he just bought more.
Valeant Pharmaceuticals International, Inc. (VRX.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||28.55 - 29.42|
|52wk Range||24.32 - 167.30|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-9.85|
|Avg Vol (3m)||1,048,222|
|Dividend & Yield||0.00 (0.00%)|